Deferred Tax Assets, Valuation Allowance of ARTELO BIOSCIENCES, INC. from 31 Aug 2014 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: ARTELO BIOSCIENCES, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Aug 2014 to 31 Dec 2025.
ARTELO BIOSCIENCES, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $7,817,000, a 38% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$7,817,000	+$2,139,000	+38%	31 Dec 2025	10-K	24 Feb 2026	2025	FY
Q4 2024	$5,678,000	+$543,000	+11%	31 Dec 2024	10-K	24 Feb 2026	2025	FY
Q4 2023	$5,135,000	+$797,000	+18%	31 Dec 2023	8-K	11 Jul 2025
Q4 2022	$4,338,000	+$995,000	+30%	31 Dec 2022	10-K	25 Mar 2024	2023	FY
Q4 2021	$3,343,000			31 Dec 2021	10-K	31 Mar 2023	2022	FY
Q3 2021	$3,864,000	+$2,066,000	+115%	31 Aug 2021	10-K	31 Mar 2023	2022	FY
Q3 2020	$1,798,000	+$739,276	+70%	31 Aug 2020	10-KT	21 Mar 2022	2022	Q1
Q3 2019	$1,058,724	+$479,765	+83%	31 Aug 2019	10-K	04 Nov 2020	2020	FY
Q3 2018	$578,959	+$478,629	+477%	31 Aug 2018	10-K/A	18 Dec 2019	2019	FY
Q3 2017	$100,330	+$79,862	+390%	31 Aug 2017	10-K	29 Nov 2018	2018	FY
Q3 2016	$20,468	+$10,095	+97%	31 Aug 2016	10-K	29 Nov 2017	2017	FY
Q3 2015	$10,373	+$15,564		31 Aug 2015	10-K	29 Nov 2016	2016	FY
Q2 2015	$8,812			31 May 2015	10-Q	15 Jul 2015	2015	Q3
Q1 2015	$7,962			28 Feb 2015	10-Q	14 Apr 2015	2015	Q2
Q3 2014	$5,191			31 Aug 2014	10-K	11 Dec 2015	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.